Dallas-based MedCognetics and its academic R&D partners will have $750,000 more to spend refining diversity-calibrated AI for early detection of breast cancer, thanks to the NIH’s “AIM-AHEAD” initiative.

A multidisciplinary center dedicated to early detection of cancer in ostensibly healthy individuals has demonstrated the soundness of its founding concept, cost-effectively catching cancers of many kinds before the onset of symptoms.

The increase has been especially evident in single-encounter chest/abdominopelvic scans, not least those performed for minor injuries.

According to the Federal Register, the FDA is repealing these radiation protection recommendations because they have become “outdated” and “unnecessary.” 

Kroger’s latest move underscores how large companies in other industries are making their way into the healthcare space.

The device, designed to be worn for up to 24 hours at a time, uses ultrasound technology and artificial intelligence to track how much blood the user's heart is pumping.